首页> 外文期刊>Sensors and Actuators >A dual usage smart sorbent/recognition element based on nanostructured conducting molecularly imprinted polypyrrole for simultaneous potential-induced nanoextraction/determination of ibuprofen in biomedical samples by quartz crystal microbalance sensor
【24h】

A dual usage smart sorbent/recognition element based on nanostructured conducting molecularly imprinted polypyrrole for simultaneous potential-induced nanoextraction/determination of ibuprofen in biomedical samples by quartz crystal microbalance sensor

机译:一种基于纳米结构的导电分子印迹聚吡咯的双重用途智能吸附剂/识别元件,用于通过石英晶体微天平传感器同时电势诱导生物医学样品中布洛芬的纳米萃取/测定

获取原文
获取原文并翻译 | 示例
       

摘要

A selective detection strategy presented for ibuprofen (IBP) as a model anionic drug based on potential-induced uptake/release of the drug by a smart conducting molecularly imprinted polymer (CMIP) as sorbent/recognition element for simultaneous nanoextraction and determination of IBP in plasma samples by quartz crystal microbalance (QCM) without any additional treatment. The nanostructured CMIP film was directly synthesized by cyclic voltammetry method on the QCM gold electrode and applied for selective uptake of IBP from sample solution by the aid of positive potential and its successive release by negative potential. The frequency shifts of QCM in uptake and release steps were monitored and used as sensor signal for IBP sorption/determination. In the biomedical samples, the frequency shift of release step exhibited more linear and interference free behavior. Several parameters like synthesis conditions, potential, time, pH of uptake and release and exchange anion type were explored to achieve the optimal sorption/determination conditions. The calibration graph was linear in the ranges of 1-10 and 10-100 μmol L~(-1), the limit of detection was 0.05 μmol L~(-1) and RSD% (n = 5) was lower than 3%. The proposed method was successfully applied for quantification of trace amounts of IBP in biomedical samples and validated by HPLC method. The CMIP/QCM sensor shows a good long-term stability and the sensor response drops 10% after 80 cycles of measurement in 8th week.
机译:针对布洛芬(IBP)作为模型阴离子药物提出了一种选择性检测策略,该方法基于智能导电分子印迹聚合物(CMIP)作为吸附剂/识别元件的潜在诱导的药物吸收/释放,以同时进行纳米提取和血浆中IBP的测定石英晶体微量天平(QCM)进行样品处理,无需任何其他处理。通过循环伏安法在QCM金电极上直接合成纳米结构CMIP膜,并利用正电势从样品溶液中选择性摄取IBP,然后通过负电势连续释放。监测QCM在摄取和释放步骤中的频移,并用作IBP吸附/测定的传感器信号。在生物医学样品中,释放步骤的频移表现出更线性和无干扰的行为。探索了几个参数,如合成条件,电势,时间,pH的吸收,释放和交换阴离子类型,以实现最佳的吸附/测定条件。校正曲线在1-10和10-100μmolL〜(-1)范围内呈线性关系,检出限为0.05μmolL〜(-1),RSD%(n = 5)低于3% 。该方法成功地用于生物医学样品中痕量IBP的定量,并通过HPLC方法进行了验证。 CMIP / QCM传感器显示出良好的长期稳定性,在第8周进行80个测量周期后,传感器响应下降10%。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号